Accolade, Inc. (ACCD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 18.74 |
| Open | 18.37 |
| Bid | 17.00 x 900 |
| Ask | 23.20 x 1300 |
| Day's Range | 17.77 - 18.92 |
| 52 Week Range | 17.53 - 58.11 |
| Volume | |
| Avg. Volume | 893,393 |
| Market Cap | 1.198B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.65 |
| Earnings Date | Jan. 10, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.73 |
- GlobeNewswire
Accolade to Participate in the 24th Annual Needham Growth Conference
SEATTLE, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, will participate in 24th Annual Needham Growth Conference, including a presentation on Friday, January 14, 2022 at 12:30 p.m. E.T. A webcast and related presentation materials will be available at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exceptional healthcare experience
